Answers are grounded in this paper and cite their sources.
(Re-)initiation of TNF antagonists and JAK inhibitors may be relatively safe in patients with current or previous TB and the need for further treatment of underlying diseases.
No takes yet. Share an insight, caveat, or question.
Brehm et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: